Aggressive Tx in Oligometastatic NSCLC Tied to Improved OS Histology, intrathoracic disease burden, and bone metastases may predict outcomes Mar 12, 2019
Liquid Biopsy Matches Tissue for NSCLC Guidance Increased mutation detection rate, faster turnaround time Feb 27, 2019
Rapid Heart Rate Tied to Higher Mortality in Cancer Patients Unexplained tachycardia linked with threefold increase in risk of death Jan 28, 2019
Cancer Treatment and Arthritis: A Growing Complaint Will checkpoint inhibitor-related arthritis outstrip RA in frequency? Dec 27, 2018
Increased Risk of Chemo-Associated AML for Nearly All Solid Cancers Extended beyond 5 years for most types with greater risk seen in young patients Dec 20, 2018
Immunotherapy Combo Flops in Metastatic NSCLC Durvalumab plus tremelimumab failed to improve survival versus chemotherapy Dec 13, 2018
Highlights from Molecular Targets Symposiuim Breast cancer gene expression, activity in GI, lung, and limited-mutation tumors Nov 16, 2018
Group of Blood Pressure Drugs Linked to Lung Cancer 14% higher likelihood in users of ACE inhibitors; causal relationship unproven Oct 25, 2018
Hippocampus-Sparing Radiation a New Option in Brain Mets Patients Approach preserved cognitive function, but patient prognosis a key consideration Oct 24, 2018
Aggressive RT, Surgery Doubles OS in NSCLC With Limited Mets If new drug produced such a response it would make "millions," said expert Oct 22, 2018 video
SBRT Doubles 5-Year Survival in Oligometastatic Cancers Most patients in phase II trial had up to three metastatic lesions Oct 17, 2018
Lung Screening Saves Lives, but Who Should Be Screened? Experts debate controversial screening issues in meeting "Smackdown" Oct 11, 2018
Lung Cancer Screening Rates Fall Short in VA Adherence was 77% among those with negative baseline screens Oct 04, 2018
More Evidence that Screening Cuts Lung Cancer Deaths Significantly lower risk in men and women Sep 26, 2018
Newer ALK Inhibitor Tops Standard in NSCLC Significant improvement in PFS with brigatinib after short follow-up Sep 26, 2018
Anti-PD-L1 Drug Boosts Survival in Stage III NSCLC New standard of care for patients with inoperable disease Sep 26, 2018
Add-On Keytruda Boosts OS in Advanced Squamous Lung Cancer Benefit seen across all subgroups, PD-L1 expression levels Sep 25, 2018
No Survival Benefit with Cranial RT for NSCLC Better disease-free survival, fewer brain mets Sep 25, 2018
Nothing Good for Older Lung Cancer Patients From Add-On Cisplatin Two trials show no survival benefit and more toxicity Jul 26, 2018
Surveillance Not Resection Called Best For Subsolid Lung Nodules Opacities tied to increase in lung cancers, but never fatal during a decade of follow-up Jul 25, 2018
Keytruda Alone Bests Chemo in Advanced NSCLC Monotherapy boosts survival in patients with low PD-L1, no EGFR or ALK alterations Jun 04, 2018
Refusing Lung Cancer Treatment: Class Trumps Race Wide variation in groups at highest risk of turning down treatment May 25, 2018
Lung Cancer Screening Rates Disappoint Evidence shows benefit for high-risk smokers but few get tested May 17, 2018
'Unsolved Mysteries' on Display at AACR Large, diverse program reflects rapid pace of advancement Apr 13, 2018
ACS: E-Cigarettes OK for Smoking Cessation ... with Caveats Short period of dual use OK, if goal is to quit Feb 22, 2018
Weather Not a Factor in Pneumothorax Risk with Lung Biopsy No relationship seen between complications and atmospheric conditions Nov 27, 2017
Shared Decision-Making Strategies for Lung Ca Screening Get High Marks Patient satisfaction high with physician-led and web-based approaches Nov 02, 2017
Genomic Testing Helps Cancer Patients -- When Results are Used Also, liquid biopsy can ID drug-responsive tumors Jun 06, 2017
Dacomitinib Sets PFS Record in Phase III NSCLC Trial Next-gen EGFR inhibitor wins head-to-head battle with gefitinib, at least for efficacy Jun 06, 2017
Immunotherapy Shows Promise in Tough-to-Treat Mesothelioma Outcomes improved with nivolumab alone or with ipilimumab in pretreated patients Jun 05, 2017
Advanced Ca Patients Benefit from Online Symptom Reports Patient-reported outcomes tied to increased survival Jun 05, 2017
Novel Agent Shows Antitumor Activity in TRK-Fusion Cancers Tumor genetics define treatment approach in early-stage trials Jun 04, 2017
Asthma Biologic, Rally Among ATS Highlights Attendees to organize on Capitol Hill; will also hear benralizumab phase III results May 17, 2017
ESTRO: Tumor-Adapted RT Lowers Pneumonitis in Lung Cancer Selected presentations from the European RT meeting May 07, 2017
MSK Cancer Alliance: Mainly About Medicine Bi-directional relationship strengthens regional cancer care Mar 11, 2017
